Content about Thomson Reuters Pharma

November 29, 2012
Eclipsing off-patent Lipitor, Humira tops Rx sales list

Just how much of an impact the loss of patent protection can have on a blockbuster drug became clear earlier this year.


Just how much of an impact the loss of patent protection can have on a blockbuster drug became clear earlier this year.


April 11, 2012
Reports: Humira to become top-selling drug this year

Move over, Lipitor: There's a new top drug on the market, according to published reports.

NEW YORK — Move over, Lipitor: There's a new top drug on the market, according to published reports.